Catalent Enters into Gene Therapy Manufacturing Collaboration with AavantiBio

  • by
Under the terms of the agreement, Catalent will handle the process development and CGMP manufacturing of AavantiBio’s adeno-associated viral vector-based therapeutic candidate for use in clinical trials in the US and Europe.